Company research / ETON
Eton Pharmaceuticals, Inc. (ETON)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Eton Pharmaceuticals, Inc. reported revenue of $79.95M. Revenue grew 104.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $105.59M.
Key ratios (year ended 2025-12-31)
53.5%
Gross margin
-1.1%
Operating margin
-5.8%
Net margin
-17.6%
Return on year-end equity
104.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.